Collegium Pharmaceutical, Inc
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Collegium Pharmaceutical, Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- +22 vs. Q4 2022
- Shares held
- 39.1M
- +3.15M (+8.8%) vs. Q4 2022
- Total value
- $936.9M
- +$103.8M (+12.5%) vs. Q4 2022
- New holders
- 47
- 66 more added
- Sold out
- 25
- 64 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COLL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 279 | $1.42B |
| Q1 2026 | 267 | $1.26B |
| Q4 2025 | 279 | $1.72B |
| Q3 2025 | 243 | $1.29B |
| Q2 2025 | 223 | $1.06B |
| Q1 2025 | 241 | $1.10B |
| Q4 2024 | 238 | $1.06B |
| Q3 2024 | 249 | $1.49B |
| Q2 2024 | 229 | $1.28B |
| Q1 2024 | 228 | $1.54B |
| Q4 2023 | 193 | $1.21B |
| Q3 2023 | 175 | $865.2M |
| Q2 2023 | 178 | $843.5M |
| Q1 2023 | 199 | $936.9M |
| Q4 2022 | 179 | $837.7M |
| Q3 2022 | 169 | $574.6M |
| Q2 2022 | 157 | $645.5M |
| Q1 2022 | 172 | $733.9M |
| Q4 2021 | 159 | $669.4M |
| Q3 2021 | 155 | $719.5M |
| Q2 2021 | 159 | $898.3M |
| Q1 2021 | 163 | $900.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Collegium Pharmaceutical, Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −167,816−100.0% | Sold out |
| SG Capital Management LLC | 0 | $0 | 0.00% | −98,762−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −77,435−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −28,750−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −25,804−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −19,596−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −14,477−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −13,370−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −8,119−100.0% | Sold out |
| AXS Investments LLC | 0 | $0 | 0.00% | −4,157−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,851−100.0% | Sold out |
| U.S. Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −1,215−100.0% | Sold out |
| MinichMacGregor Wealth Management, LLC | 0 | $0 | 0.00% | −680−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −276−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| McElhenny Sheffield Capital Management, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Monarch Partners Asset Management LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |